HEADER HYDROLASE 07-SEP-21 7VE0 TITLE CRYSTAL STRUCTURE OF RITONAVIR BOUND PLASMEPSIN II (PMII) FROM TITLE 2 PLASMODIUM FALCIPARUM COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMEPSIN II; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.23.39; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM (ISOLATE 3D7); SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: ISOLATE 3D7; SOURCE 5 GENE: PF3D7_1408000; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA-GAMI B(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET32B KEYWDS INHIBITOR, PROTEASE, PEPTIDOMIMETIC, HIV-1 PROTEASE INHIBITOR, KEYWDS 2 PEPTIDASE, HEMOGLOBIN DEGRADER, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR V.MISHRA,I.RATHORE,P.BHAUMIK REVDAT 4 23-OCT-24 7VE0 1 REMARK REVDAT 3 06-MAR-24 7VE0 1 JRNL REVDAT 2 29-NOV-23 7VE0 1 REMARK REVDAT 1 01-FEB-23 7VE0 0 JRNL AUTH V.MISHRA,A.DESHMUKH,I.RATHORE,S.CHAKRABORTY,S.PATANKAR, JRNL AUTH 2 A.GUSTCHINA,A.WLODAWER,R.Y.YADA,P.BHAUMIK JRNL TITL INHIBITION OF PLASMODIUM FALCIPARUM PLASMEPSINS BY DRUGS JRNL TITL 2 TARGETING HIV-1 PROTEASE: A WAY FORWARD FOR ANTIMALARIAL JRNL TITL 3 DRUG DISCOVERY. JRNL REF CURR RES STRUCT BIOL V. 7 00128 2024 JRNL REFN ESSN 2665-928X JRNL PMID 38304146 JRNL DOI 10.1016/J.CRSTBI.2024.100128 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH V.MISHRA,I.RATHORE,P.BHAUMIK REMARK 1 TITL MOLECULAR INSIGHTS INTO THE INHIBITION OF PLASMEPSINS BY REMARK 1 TITL 2 HIV-1 PROTEASE INHIBITORS: IMPLICATIONS FOR ANTIMALARIAL REMARK 1 TITL 3 DRUG DISCOVERY. REMARK 1 REF BIORXIV 2023 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2021.09.27.461917 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 58262 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3067 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4206 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.25 REMARK 3 BIN R VALUE (WORKING SET) : 0.3560 REMARK 3 BIN FREE R VALUE SET COUNT : 221 REMARK 3 BIN FREE R VALUE : 0.3290 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5189 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 567 REMARK 3 SOLVENT ATOMS : 365 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.24 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.55000 REMARK 3 B22 (A**2) : -5.03000 REMARK 3 B33 (A**2) : 0.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.21000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.188 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.167 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.172 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.327 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6072 ; 0.004 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 5733 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8391 ; 1.309 ; 1.672 REMARK 3 BOND ANGLES OTHERS (DEGREES): 13342 ; 1.080 ; 1.603 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 674 ; 7.502 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 257 ;35.682 ;25.175 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 885 ;14.629 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;21.774 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 893 ; 0.045 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6386 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1271 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2654 ; 0.405 ; 1.647 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2653 ; 0.405 ; 1.647 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3324 ; 0.722 ; 2.468 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3325 ; 0.722 ; 2.468 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3418 ; 0.586 ; 2.489 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 3419 ; 0.586 ; 2.490 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 5062 ; 0.985 ; 3.768 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6400 ; 7.676 ;25.787 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 6329 ; 7.659 ;25.144 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 8 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 3 A 17 REMARK 3 ORIGIN FOR THE GROUP (A): 16.6618 12.9122 3.1268 REMARK 3 T TENSOR REMARK 3 T11: 0.1845 T22: 0.4468 REMARK 3 T33: 0.1756 T12: -0.0379 REMARK 3 T13: -0.1266 T23: -0.0936 REMARK 3 L TENSOR REMARK 3 L11: 8.1036 L22: 6.5960 REMARK 3 L33: 30.8103 L12: -1.6197 REMARK 3 L13: 15.0661 L23: -5.1227 REMARK 3 S TENSOR REMARK 3 S11: -0.1200 S12: -0.2285 S13: -0.1685 REMARK 3 S21: -0.0505 S22: 0.1396 S23: 0.1665 REMARK 3 S31: -0.1689 S32: -0.7154 S33: -0.0196 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 18 A 196 REMARK 3 ORIGIN FOR THE GROUP (A): 26.1839 18.3592 -3.8187 REMARK 3 T TENSOR REMARK 3 T11: 0.4488 T22: 0.5138 REMARK 3 T33: 0.1289 T12: 0.0094 REMARK 3 T13: -0.2110 T23: -0.0174 REMARK 3 L TENSOR REMARK 3 L11: 1.5500 L22: 1.5918 REMARK 3 L33: 2.7155 L12: -0.9581 REMARK 3 L13: -0.5391 L23: 0.1105 REMARK 3 S TENSOR REMARK 3 S11: 0.0605 S12: 0.1297 S13: -0.0521 REMARK 3 S21: -0.5420 S22: -0.0855 S23: 0.1631 REMARK 3 S31: 0.1677 S32: -0.1950 S33: 0.0251 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 197 A 277 REMARK 3 ORIGIN FOR THE GROUP (A): 23.0572 26.2256 23.2797 REMARK 3 T TENSOR REMARK 3 T11: 0.1887 T22: 0.4373 REMARK 3 T33: 0.1329 T12: 0.0148 REMARK 3 T13: -0.1172 T23: -0.0096 REMARK 3 L TENSOR REMARK 3 L11: 0.8200 L22: 1.4977 REMARK 3 L33: 4.4439 L12: -0.3724 REMARK 3 L13: -0.0006 L23: -1.3252 REMARK 3 S TENSOR REMARK 3 S11: 0.0212 S12: -0.0914 S13: 0.0723 REMARK 3 S21: 0.0869 S22: 0.0647 S23: 0.1075 REMARK 3 S31: -0.4656 S32: -0.3507 S33: -0.0859 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 278 A 331 REMARK 3 ORIGIN FOR THE GROUP (A): 19.7282 22.7381 13.6880 REMARK 3 T TENSOR REMARK 3 T11: 0.1698 T22: 0.4047 REMARK 3 T33: 0.1282 T12: 0.0321 REMARK 3 T13: -0.1446 T23: -0.0372 REMARK 3 L TENSOR REMARK 3 L11: 2.9998 L22: 1.8646 REMARK 3 L33: 6.2714 L12: -0.2760 REMARK 3 L13: 1.2466 L23: -1.2337 REMARK 3 S TENSOR REMARK 3 S11: 0.1881 S12: -0.1516 S13: -0.1784 REMARK 3 S21: -0.2712 S22: -0.0681 S23: 0.1743 REMARK 3 S31: 0.3055 S32: -0.4346 S33: -0.1200 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 4 B 34 REMARK 3 ORIGIN FOR THE GROUP (A): 3.5671 -22.5304 22.1320 REMARK 3 T TENSOR REMARK 3 T11: 0.1901 T22: 0.4794 REMARK 3 T33: 0.3270 T12: 0.0350 REMARK 3 T13: -0.0263 T23: -0.0877 REMARK 3 L TENSOR REMARK 3 L11: 7.4625 L22: 5.9109 REMARK 3 L33: 3.6270 L12: 0.0701 REMARK 3 L13: 0.4931 L23: 0.4419 REMARK 3 S TENSOR REMARK 3 S11: -0.0860 S12: 0.6487 S13: -0.4945 REMARK 3 S21: -0.3348 S22: 0.1183 S23: -0.8056 REMARK 3 S31: 0.2356 S32: 0.4048 S33: -0.0323 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 35 B 218 REMARK 3 ORIGIN FOR THE GROUP (A): 2.4341 -12.9814 27.0853 REMARK 3 T TENSOR REMARK 3 T11: 0.1150 T22: 0.5514 REMARK 3 T33: 0.3385 T12: 0.0033 REMARK 3 T13: -0.0751 T23: -0.0189 REMARK 3 L TENSOR REMARK 3 L11: 3.0142 L22: 2.5889 REMARK 3 L33: 1.2666 L12: 0.2660 REMARK 3 L13: 1.0348 L23: -0.7697 REMARK 3 S TENSOR REMARK 3 S11: -0.1748 S12: 0.5204 S13: 0.0284 REMARK 3 S21: -0.2154 S22: 0.0676 S23: -0.6348 REMARK 3 S31: 0.0421 S32: 0.2050 S33: 0.1072 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 219 B 277 REMARK 3 ORIGIN FOR THE GROUP (A): -23.3307 -11.0346 23.4112 REMARK 3 T TENSOR REMARK 3 T11: 0.1535 T22: 0.4844 REMARK 3 T33: 0.1678 T12: 0.0101 REMARK 3 T13: -0.1408 T23: 0.0242 REMARK 3 L TENSOR REMARK 3 L11: 3.9294 L22: 1.6770 REMARK 3 L33: 1.1968 L12: 1.3999 REMARK 3 L13: 0.2972 L23: -0.2594 REMARK 3 S TENSOR REMARK 3 S11: -0.1759 S12: 0.4793 S13: 0.4224 REMARK 3 S21: -0.1901 S22: 0.0814 S23: 0.1150 REMARK 3 S31: -0.0623 S32: 0.0461 S33: 0.0944 REMARK 3 REMARK 3 TLS GROUP : 8 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 278 B 329 REMARK 3 ORIGIN FOR THE GROUP (A): -12.2506 -11.0263 21.1088 REMARK 3 T TENSOR REMARK 3 T11: 0.1976 T22: 0.4664 REMARK 3 T33: 0.1836 T12: 0.0154 REMARK 3 T13: -0.0765 T23: 0.0508 REMARK 3 L TENSOR REMARK 3 L11: 6.6069 L22: 2.0669 REMARK 3 L33: 3.1812 L12: 1.5221 REMARK 3 L13: -1.0948 L23: 0.1142 REMARK 3 S TENSOR REMARK 3 S11: -0.1231 S12: 0.5613 S13: -0.0687 REMARK 3 S21: -0.3285 S22: 0.0609 S23: -0.2769 REMARK 3 S31: 0.1586 S32: -0.0307 S33: 0.0621 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 7VE0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-SEP-21. REMARK 100 THE DEPOSITION ID IS D_1300024360. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : RRCAT INDUS-2 REMARK 200 BEAMLINE : PX-BL21 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61329 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 39.890 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 200 DATA REDUNDANCY : 2.890 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.1600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.73 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.840 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5YIC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5 M SODIUM FORMATE, PH 7.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 75.14500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.20500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 75.14500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.20500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 1 REMARK 465 GLY A 2 REMARK 465 LEU B 1 REMARK 465 GLY B 2 REMARK 465 SER B 3 REMARK 465 ASN B 330 REMARK 465 LEU B 331 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 585 O HOH B 630 1.93 REMARK 500 OE1 GLN A 196 O2 CPS A 407 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 4 -100.58 49.47 REMARK 500 ASN A 5 114.29 -171.46 REMARK 500 ILE A 16 -22.71 -143.25 REMARK 500 ASP A 71 -73.32 -120.22 REMARK 500 LEU A 193 37.75 -145.63 REMARK 500 PHE A 243 -2.19 79.91 REMARK 500 PRO A 245 34.60 -83.22 REMARK 500 LYS A 329 -73.15 -70.05 REMARK 500 ILE B 16 -32.37 -135.30 REMARK 500 ASP B 71 -75.53 -130.90 REMARK 500 LYS B 165 -57.62 -137.09 REMARK 500 LEU B 193 31.21 -140.19 REMARK 500 PHE B 243 -3.96 79.39 REMARK 500 PRO B 245 38.53 -85.33 REMARK 500 ASN B 253 108.55 -57.05 REMARK 500 ASN B 253 109.03 -57.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE A 33 ILE A 34 147.60 REMARK 500 PHE B 33 ILE B 34 148.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 660 DISTANCE = 6.08 ANGSTROMS REMARK 525 HOH B 661 DISTANCE = 6.54 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CPS A 403 REMARK 610 CPS A 404 REMARK 610 CPS A 405 REMARK 610 CPS A 406 REMARK 610 CPS A 408 REMARK 610 CPS B 402 REMARK 610 CPS B 403 REMARK 610 CPS B 404 REMARK 610 CPS B 405 REMARK 610 CPS B 406 REMARK 610 CPS B 407 REMARK 610 CPS B 408 REMARK 610 CPS B 409 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: RITONAVIR REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 RIT A 401 REMARK 630 RIT B 401 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 013 015 VAL 019 REMARK 630 DETAILS: NULL DBREF 7VE0 A 1 331 UNP Q8I6V3 Q8I6V3_PLAF7 123 453 DBREF 7VE0 B 1 331 UNP Q8I6V3 Q8I6V3_PLAF7 123 453 SEQRES 1 A 331 LEU GLY SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE SEQRES 2 A 331 GLN ASN ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP SEQRES 3 A 331 ASN GLN GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER SEQRES 4 A 331 ALA ASN LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA SEQRES 5 A 331 GLY CYS LEU THR LYS HIS LEU TYR ASP SER SER LYS SER SEQRES 6 A 331 ARG THR TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN SEQRES 7 A 331 TYR VAL SER GLY THR VAL SER GLY PHE PHE SER LYS ASP SEQRES 8 A 331 LEU VAL THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE SEQRES 9 A 331 ILE GLU VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR SEQRES 10 A 331 THR ALA SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP SEQRES 11 A 331 LYS ASP LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL SEQRES 12 A 331 GLU LEU LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE SEQRES 13 A 331 THR PHE TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE SEQRES 14 A 331 LEU THR ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY SEQRES 15 A 331 PRO LEU THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP SEQRES 16 A 331 GLN ILE THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU SEQRES 17 A 331 GLU LYS ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA SEQRES 18 A 331 ILE THR VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN SEQRES 19 A 331 ASN LEU ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR SEQRES 20 A 331 VAL THR LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU SEQRES 21 A 331 PHE THR SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU SEQRES 22 A 331 TYR TYR LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU SEQRES 23 A 331 CYS MET LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO SEQRES 24 A 331 THR PHE ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE SEQRES 25 A 331 THR VAL PHE ASP TYR ASP ASN GLN SER VAL GLY ILE ALA SEQRES 26 A 331 LEU ALA LYS LYS ASN LEU SEQRES 1 B 331 LEU GLY SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE SEQRES 2 B 331 GLN ASN ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP SEQRES 3 B 331 ASN GLN GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER SEQRES 4 B 331 ALA ASN LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA SEQRES 5 B 331 GLY CYS LEU THR LYS HIS LEU TYR ASP SER SER LYS SER SEQRES 6 B 331 ARG THR TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN SEQRES 7 B 331 TYR VAL SER GLY THR VAL SER GLY PHE PHE SER LYS ASP SEQRES 8 B 331 LEU VAL THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE SEQRES 9 B 331 ILE GLU VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR SEQRES 10 B 331 THR ALA SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP SEQRES 11 B 331 LYS ASP LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL SEQRES 12 B 331 GLU LEU LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE SEQRES 13 B 331 THR PHE TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE SEQRES 14 B 331 LEU THR ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY SEQRES 15 B 331 PRO LEU THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP SEQRES 16 B 331 GLN ILE THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU SEQRES 17 B 331 GLU LYS ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA SEQRES 18 B 331 ILE THR VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN SEQRES 19 B 331 ASN LEU ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR SEQRES 20 B 331 VAL THR LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU SEQRES 21 B 331 PHE THR SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU SEQRES 22 B 331 TYR TYR LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU SEQRES 23 B 331 CYS MET LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO SEQRES 24 B 331 THR PHE ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE SEQRES 25 B 331 THR VAL PHE ASP TYR ASP ASN GLN SER VAL GLY ILE ALA SEQRES 26 B 331 LEU ALA LYS LYS ASN LEU HET RIT A 401 50 HET CPS A 402 42 HET CPS A 403 26 HET CPS A 404 29 HET CPS A 405 23 HET CPS A 406 29 HET CPS A 407 42 HET CPS A 408 36 HET EDO A 409 4 HET RIT B 401 100 HET CPS B 402 29 HET CPS B 403 36 HET CPS B 404 29 HET CPS B 405 30 HET CPS B 406 29 HET CPS B 407 22 HET CPS B 408 27 HET CPS B 409 30 HET EDO B 410 4 HETNAM RIT RITONAVIR HETNAM CPS 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1- HETNAM 2 CPS PROPANESULFONATE HETNAM EDO 1,2-ETHANEDIOL HETSYN RIT A-84538 HETSYN CPS CHAPS HETSYN EDO ETHYLENE GLYCOL FORMUL 3 RIT 2(C37 H48 N6 O5 S2) FORMUL 4 CPS 15(C32 H58 N2 O7 S) FORMUL 11 EDO 2(C2 H6 O2) FORMUL 22 HOH *365(H2 O) HELIX 1 AA1 THR A 51 LYS A 57 5 7 HELIX 2 AA2 ASP A 61 SER A 65 5 5 HELIX 3 AA3 THR A 110 GLU A 114 5 5 HELIX 4 AA4 PRO A 115 SER A 120 1 6 HELIX 5 AA5 TRP A 130 SER A 134 5 5 HELIX 6 AA6 PRO A 140 GLN A 148 1 9 HELIX 7 AA7 GLU A 176 ARG A 178 5 3 HELIX 8 AA8 PRO A 225 GLN A 234 1 10 HELIX 9 AA9 GLU A 271 TYR A 275 1 5 HELIX 10 AB1 GLY A 304 LYS A 310 1 7 HELIX 11 AB2 THR B 51 LYS B 57 5 7 HELIX 12 AB3 ASP B 61 SER B 65 5 5 HELIX 13 AB4 THR B 110 GLU B 114 5 5 HELIX 14 AB5 PRO B 115 SER B 120 1 6 HELIX 15 AB6 TRP B 130 SER B 134 5 5 HELIX 16 AB7 PRO B 140 GLN B 148 1 9 HELIX 17 AB8 GLU B 176 ARG B 178 5 3 HELIX 18 AB9 PRO B 225 LEU B 233 1 9 HELIX 19 AC1 GLU B 271 TYR B 275 1 5 HELIX 20 AC2 GLU B 280 GLY B 283 5 4 HELIX 21 AC3 GLY B 304 LYS B 310 1 7 SHEET 1 AA1 9 GLU A 69 TYR A 79 0 SHEET 2 AA1 9 GLY A 82 VAL A 95 -1 O LYS A 90 N GLU A 69 SHEET 3 AA1 9 MET A 17 VAL A 24 -1 N GLU A 23 O THR A 94 SHEET 4 AA1 9 ASP A 6 PHE A 13 -1 N PHE A 13 O MET A 17 SHEET 5 AA1 9 GLY A 168 ILE A 172 -1 O ILE A 172 N ASP A 6 SHEET 6 AA1 9 LEU A 155 TYR A 159 -1 N TYR A 159 O PHE A 169 SHEET 7 AA1 9 TYR A 311 ASP A 316 -1 O PHE A 315 N PHE A 156 SHEET 8 AA1 9 SER A 321 ALA A 327 -1 O GLY A 323 N VAL A 314 SHEET 9 AA1 9 TYR A 180 LYS A 188 -1 N GLU A 187 O VAL A 322 SHEET 1 AA213 GLU A 69 TYR A 79 0 SHEET 2 AA213 GLY A 82 VAL A 95 -1 O LYS A 90 N GLU A 69 SHEET 3 AA213 LEU A 98 ASP A 109 -1 O GLU A 106 N PHE A 87 SHEET 4 AA213 LEU A 42 PRO A 45 1 N LEU A 42 O ILE A 105 SHEET 5 AA213 GLY A 124 GLY A 127 -1 O ILE A 125 N TRP A 43 SHEET 6 AA213 GLN A 29 ASP A 36 1 N ILE A 34 O LEU A 126 SHEET 7 AA213 MET A 17 VAL A 24 -1 N GLY A 20 O PHE A 33 SHEET 8 AA213 ASP A 6 PHE A 13 -1 N PHE A 13 O MET A 17 SHEET 9 AA213 GLY A 168 ILE A 172 -1 O ILE A 172 N ASP A 6 SHEET 10 AA213 LEU A 155 TYR A 159 -1 N TYR A 159 O PHE A 169 SHEET 11 AA213 TYR A 311 ASP A 316 -1 O PHE A 315 N PHE A 156 SHEET 12 AA213 SER A 321 ALA A 327 -1 O GLY A 323 N VAL A 314 SHEET 13 AA213 TYR A 180 LYS A 188 -1 N GLU A 187 O VAL A 322 SHEET 1 AA3 7 LYS A 267 LEU A 270 0 SHEET 2 AA3 7 PHE A 259 THR A 262 -1 N PHE A 261 O TYR A 268 SHEET 3 AA3 7 GLN A 196 VAL A 203 -1 N HIS A 202 O GLU A 260 SHEET 4 AA3 7 ILE A 206 VAL A 215 -1 O CYS A 213 N ILE A 197 SHEET 5 AA3 7 THR A 300 LEU A 303 1 O LEU A 303 N ILE A 214 SHEET 6 AA3 7 ILE A 222 VAL A 224 -1 N THR A 223 O ILE A 302 SHEET 7 AA3 7 ILE A 291 GLY A 293 1 O ILE A 292 N VAL A 224 SHEET 1 AA4 4 ILE A 239 LYS A 240 0 SHEET 2 AA4 4 TYR A 247 LEU A 250 -1 O VAL A 248 N ILE A 239 SHEET 3 AA4 4 LEU A 286 LEU A 289 -1 O CYS A 287 N THR A 249 SHEET 4 AA4 4 LEU A 276 HIS A 278 -1 N GLN A 277 O MET A 288 SHEET 1 AA5 9 GLU B 69 ASN B 78 0 SHEET 2 AA5 9 THR B 83 VAL B 95 -1 O LYS B 90 N GLU B 69 SHEET 3 AA5 9 MET B 17 VAL B 24 -1 N GLU B 23 O THR B 94 SHEET 4 AA5 9 ASP B 6 PHE B 13 -1 N VAL B 11 O TYR B 19 SHEET 5 AA5 9 GLY B 168 ILE B 172 -1 O GLY B 168 N LEU B 10 SHEET 6 AA5 9 LEU B 155 TYR B 159 -1 N THR B 157 O THR B 171 SHEET 7 AA5 9 TYR B 311 ASP B 316 -1 O PHE B 315 N PHE B 156 SHEET 8 AA5 9 SER B 321 ALA B 327 -1 O GLY B 323 N VAL B 314 SHEET 9 AA5 9 TYR B 180 LYS B 188 -1 N GLU B 187 O VAL B 322 SHEET 1 AA613 GLU B 69 ASN B 78 0 SHEET 2 AA613 THR B 83 VAL B 95 -1 O LYS B 90 N GLU B 69 SHEET 3 AA613 LEU B 98 ASP B 109 -1 O GLU B 106 N PHE B 87 SHEET 4 AA613 LEU B 42 PRO B 45 1 N LEU B 42 O ILE B 105 SHEET 5 AA613 GLY B 124 GLY B 127 -1 O ILE B 125 N TRP B 43 SHEET 6 AA613 GLN B 29 ASP B 36 1 N ASP B 36 O LEU B 126 SHEET 7 AA613 MET B 17 VAL B 24 -1 N GLY B 20 O PHE B 33 SHEET 8 AA613 ASP B 6 PHE B 13 -1 N VAL B 11 O TYR B 19 SHEET 9 AA613 GLY B 168 ILE B 172 -1 O GLY B 168 N LEU B 10 SHEET 10 AA613 LEU B 155 TYR B 159 -1 N THR B 157 O THR B 171 SHEET 11 AA613 TYR B 311 ASP B 316 -1 O PHE B 315 N PHE B 156 SHEET 12 AA613 SER B 321 ALA B 327 -1 O GLY B 323 N VAL B 314 SHEET 13 AA613 TYR B 180 LYS B 188 -1 N GLU B 187 O VAL B 322 SHEET 1 AA7 7 LYS B 267 LEU B 270 0 SHEET 2 AA7 7 PHE B 259 THR B 262 -1 N PHE B 261 O TYR B 268 SHEET 3 AA7 7 GLN B 196 VAL B 203 -1 N HIS B 202 O GLU B 260 SHEET 4 AA7 7 ILE B 206 VAL B 215 -1 O CYS B 213 N ILE B 197 SHEET 5 AA7 7 THR B 300 LEU B 303 1 O LEU B 303 N ILE B 214 SHEET 6 AA7 7 ILE B 222 VAL B 224 -1 N THR B 223 O ILE B 302 SHEET 7 AA7 7 ILE B 291 GLY B 293 1 O ILE B 292 N VAL B 224 SHEET 1 AA8 4 ILE B 239 LYS B 240 0 SHEET 2 AA8 4 TYR B 247 LEU B 250 -1 O VAL B 248 N ILE B 239 SHEET 3 AA8 4 LEU B 286 LEU B 289 -1 O CYS B 287 N THR B 249 SHEET 4 AA8 4 LEU B 276 HIS B 278 -1 N GLN B 277 O MET B 288 SSBOND 1 CYS A 49 CYS A 54 1555 1555 2.02 SSBOND 2 CYS A 251 CYS A 287 1555 1555 2.05 SSBOND 3 CYS B 49 CYS B 54 1555 1555 2.04 SSBOND 4 CYS B 251 CYS B 287 1555 1555 2.04 CISPEP 1 GLU A 114 PRO A 115 0 3.09 CISPEP 2 GLU B 114 PRO B 115 0 8.89 CISPEP 3 GLY B 283 PRO B 284 0 8.47 CRYST1 150.290 70.410 106.670 90.00 133.61 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006654 0.000000 0.006339 0.00000 SCALE2 0.000000 0.014203 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012948 0.00000